tm logo
SANFERIN
Dead/Cancelled
CANCELLED – SECTION 71

on 26 Nov 2021

Last Applicant/ Owned by

A-4600 Wels

AT

Serial Number

79150001 filed on 09th Apr 2014

Registration Number

4710120 registered on 31st Mar 2015

in the Principal Register

Correspondent Address

Lawrence E. Abelman

Abelman Frayne & Schwab

10th Floor

666 Third Avenue

New York NY 10017

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

SANFERIN

The wording "SANFERIN" has no meaning in a foreign language. Pharmaceuticals for the treatment and prevention of bacterial and viral infections and for the reinforcement of the immune system; sanitary preparations for medical purposes; dietary food supplements and pharmaceutical substances for the treatment and prevention of bacterial and viral infections and for the reinforcement of the immune sRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceuticals for the treatment and prevention of bacterial and viral infections and for the reinforcement of the immune system; sanitary preparations for medical purposes; dietary food supplements and pharmaceutical substances for the treatment and prevention of bacterial and viral infections and for the reinforcement of the immune system; food supplements for human beings

Mark Details


Serial Number

No 79150001

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 997581

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
04th Nov 2023NEW REPRESENTATIVE AT IB RECEIVED
09th Oct 2022TOTAL INVALIDATION PROCESSED BY THE IB
15th Sep 2022INVALIDATION PROCESSED
15th Sep 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
26th Jul 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
26th Nov 2021CANCELLED SECTION 71
01st Nov 2021NEW REPRESENTATIVE AT IB RECEIVED
31st Mar 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
21st Aug 2015FINAL DECISION TRANSACTION PROCESSED BY IB
31st Jul 2015FINAL DISPOSITION PROCESSED